- AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device Sales . . .
Anonymous board for AstraZeneca
- Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous discussion boards for pharmaceutical sales, medical device sales, lab diagnostics sales
- Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma
AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial BioPharma Dive Thursday, July 24, 2025 - 12:03 pm AstraZeneca, gefurulimab, myasthenia gravis, clinical trials AstraZeneca board Orthopedic implant maker Shoulder Innovations sets terms for $100M+ IPO Fierce Biotech
- Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US . . .
The modification of an existing collaboration agreement with AstraZeneca gives Sanofi full commercial control of RSV antibody Beyfortus (nirsevimab) and 'enhanced agility' in the US market
- News Feed - Cafepharma
Latest news and updates on pharmaceutical and medical sales, including breakthrough treatments and industry trends
- Pharma Biotech Companies | Cafepharma Message Boards | Pharma Sales . . .
Anonymous discussion boards for pharmaceutical and biotech companies
- AstraZeneca’s Truqap flops in phase III triple-negative breast cancer . . .
Bucking its recent winning streak in oncology, AstraZeneca reported Tuesday that its AKT inhibitor Truqap failed to significantly boost overall survival in patients with triple-negative breast cancer
- Pfizer | Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous board for Pfizer What Sales team or Support team should Pfizer say bye-bye
|